121
Views
9
CrossRef citations to date
0
Altmetric
Short Communication

Honey has an antifungal effect against Candida species

, , &
Pages 289-291 | Received 08 Aug 2005, Published online: 09 Jul 2009

References

  • Zumla A, Lulat A. Honey – a remedy rediscovered. J R Soc Med 1989; 82: 384–385
  • White JW, Subers MH, Schepartz AI. The identification of inhibine, the antibacterial factor in honey, as hydrogen peroxide and its origin in a honey glucose-oxidase system. Biochim Biophys Acta 1963; 73: 57–70
  • Molan PC. The antibacterial activity of honey. 1. The nature of the antibacterial activity. Bee World 1992; 73: 5–28
  • Cooper RA, Molan PC, Harding KG. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 2002; 93: 857–863
  • Cooper RA, Molan PC. The use of honey as an antiseptic in managing Pseudomonas infection. J Wound Care 1999; 8: 161–164
  • Abi-Said D, Anaissie E, Uzun O, et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infec Dis 1997; 24: 1122–1128
  • Pfaller MA, Diekema DJ, Jones RN, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254–3259
  • Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 1998; 31: 327–332
  • Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317–322
  • Sobel JD, Zervos M, Reed BD, et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother 2003; 47: 34–38
  • Sobel JD, Kapernick PS, Zervos M, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001; 185: 363–369
  • Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol 2002; 187: 569–574
  • Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidaemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002; 40: 3551–3557
  • Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203–211
  • Sullivan DJ, Moran GP, Pinjon E, et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369–376
  • Allen KL, Molan PC, Reid GM. A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 1991; 43: 817–822
  • Manning R. Antibacterial activity (hydrogen peroxide) of some Western Australian honeys. ( manuscript in preparation) 2005.
  • National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard, M27-A2, 2nd edn. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
  • Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infec Dis 2003; 3: 685–702
  • Theunissen F, Grobler S, Gedalia I. The antifungal action of three South African honeys on Candida albicans. Apidologie 2001; 32: 371–379
  • Efem SE, Udoh KT, Iwara CI. The antimicrobial spectrum of honey and its clinical significance. Infection 1992; 20: 227–229
  • Adeleye IA, Opiah L. Antimicrobial activity of extracts of local cough mixtures on upper respiratory tract bacterial pathogens. West Indian Med J 2003; 52: 188–190
  • Brady NF, Molan PC, Harfoot CG. The sensitivity of dermatophytes to the antimicrobial activity of manuka honey and other honey. Pharm Sci 1996; 2: 471–473
  • Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617–623
  • Wroblewska MM, Swoboda-Kopec E, Rokosz A, et al. Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles. Int J Antimicrob Agents 2002; 20: 472–475
  • Quadri KH, Huraib SO. Manuka honey for central vein catheter exit site care. Dialysis Clinic 1999: 397–398.
  • Johnson DW, van Eps C, Mudge DW, et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1456–1462
  • English HK, Pack AR, Molan PC. The effects of manuka honey on plaque and gingivitis: a pilot study. J Int Acad Periodontol 2004; 6: 63–67
  • Efem SEE. Clinical observations on the wound healing properties of honey. Br J Surg 1988; 75: 679–681
  • Molan PC, Betts JA. Clinical usage of honey as a wound dressing: an update. J Wound Care 2004; 13: 353–356

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.